Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson’s Disease Model
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Systemic inflammation is a crucial factor for microglial activation and neuroinflammation in neurodegeneration. This work is aimed at assessing whether previous exposure to systemic inflammation potentiates neurotoxic damage by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and how chronic systemic inflammation participates in the physiopathological mechanisms of Parkinson’s disease. Two different models of systemic inflammation were employed to explore this hypothesis: a single administration of lipopolysaccharide (sLPS; 5 mg/kg) and chronic exposure to low doses (mLPS; 100 μ g/kg twice a week for three months). After three months, both groups were challenged with MPTP. With the sLPS administration, Iba1 staining increased in the striatum and substantia nigra, and the cell viability lowered in the striatum of these mice. mLPS alone had more impact on the proinflammatory profile of the brain, steadily increasing TNF α levels, activating microglia, reducing BDNF, cell viability, and dopamine levels, leading to a damage profile similar to the MPTP model per se. Interestingly, mLPS increased MAO-B activity possibly conferring susceptibility to MPTP damage. mLPS, along with MPTP administration, exacerbated the neurotoxic effect. This effect seemed to be coordinated by microglia since minocycline administration prevented brain TNF α increase. Coadministration of sLPS with MPTP only facilitated damage induced by MPTP without significant change in the inflammatory profile. These results indicate that chronic systemic inflammation increased susceptibility to MPTP toxic effect and is an adequate model for studying the impact of systemic inflammation in Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · cited 1×
“Evidence shows that brain and cerebrospinal fluid levels of norepinephrine [96] and serotonin in PD patients are decreased compared to healthy persons [97].”
BackgroundSystemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 10×
“Systemic TNFα is transported through the BBB by TNFα receptors, promoting the activation of microglial cells, releasing additional TNFα and other cytokines establishing chronic neuroinflammation [15].”
BackgroundResultInfluentialNormal aging induces A1-like astrocyte reactivity
Clarke, L. E., Liddelow, S. A., Chakraborty, C., Münch, A. E., Heiman, M., & Barres, B. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800165115 · Cited by 1,237
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172 · cited 14×
“Systemic TNFα is transported through the BBB by TNFα receptors, promoting the activation of microglial cells, releasing additional TNFα and other cytokines establishing chronic neuroinflammation [15].”
ResultInfluentialBlock of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123 · cited 1×
“Neurotoxic A1 astrocytes are present in the striatum of elderly [99], as well as in the substantia nigra and striatum of Parkinson’s disease patient [100], and are considered to be coresponsible for neuronal loss since its blocking protects dopaminergic neurons in a Parkinson’s disease murine model [101].”
BackgroundTansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
The metabolic syndrome, inflammation, and risk of cognitive decline
Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025
Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., & Johnson, R. W. (2005) · The FASEB Journal · doi:10.1096/fj.05-3776fje · Cited by 813 · cited 2×
“During aging, microglia generate higher levels of IL6, TNFα, and IL1β [86], possibly remaining in a chronic inflammatory state, similar to our model of mLPS. Interestingly, mLPS also significantly raised IFNγ in the brain, which enhances the phagocytic activity of microglia [87] and induces the expression of MHC class…”
ResultBanks, W. A., Gray, A. M., Erickson, M. A., Salameh, T. S., Damodarasamy, M., Sheibani, N., Meabon, J. S., Wing, E. E., Morofuji, Y., Cook, D. G., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0434-1 · Cited by 636 · cited 1×
“[70, 72] showed that disruption of the BBB with repeated injections of LPS did not enhance LPS entry into the CNS, and the effects of peripherally A A B B B B Controls MPTP 4”
BackgroundA trans-dimensional approach to the behavioral aspects of depression
Bessa, J. M. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.001.2009 · Cited by 469 · cited 1×
“A percentage lower than 65% of consumption was considered anhedonia [34].”
BackgroundRegulation of TGF-β Family Signaling by Inhibitory Smads
Miyazawa, K., & Miyazono, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022095 · Cited by 439 · cited 1×
“IFNγ via STAT1 and TNFα via NFκB induce inhibitory Smad7 expression, an antagonist of TGFβ signaling pathway, thus lowering TGFβ secretion [60, 61].”
BackgroundMinimal penetration of lipopolysaccharide across the murine blood–brain barrier
Banks, W. A., & Robinson, S. M. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.001 · Cited by 356 · cited 1×
“[70, 72] showed that disruption of the BBB with repeated injections of LPS did not enhance LPS entry into the CNS, and the effects of peripherally A A B B B B Controls MPTP 4”
BackgroundKoprich, J. B., Reske-Nielsen, C., Mithal, P., & Isacson, O. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-8 · Cited by 355
Activation of NADPH Oxidase in Alzheimer’s Disease Brains
Shimohama, S., Tanino, H., Kawakami, N., Okamura, N., Kodama, H., Yamaguchi, T., Hayakawa, T., Nunomura, A., Chiba, S., Perry, G., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2897 · Cited by 292
Microglial phenotypes in Parkinson’s disease and animal models of the disease
Joers, V., Tansey, M. G., Mulas, G., & Carta, A. R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.006 · Cited by 285 · cited 1×
“The inflammatory process, oxidative stress, and microglia activation are essential components in the pathogenesis of many neurodegenerative disorders such as PD [9].”
BackgroundQin, L., Liu, Y., Hong, J., & Crews, F. T. (2013) · Glia · doi:10.1002/glia.22479 · Cited by 271 · cited 3×
“Nevertheless, after the measurement of these molecules, we decided it would be more precise to evaluate in the primary two affected brain structures (striatum and substantia nigra), since the administration of peripheral LPS can induce neurodegeneration in the substantia nigra secondary to the microglial synthesis of…”
BackgroundTong, L., Prieto, G. A., Kramár, E. A., Smith, E. D., Cribbs, D. H., Lynch, G., & Cotman, C. W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1253-12.2012 · Cited by 254 · cited 16×
“Cytokine and BDNF levels were evaluated in whole brain lysates.”
BackgroundInfluentialAssociation between diabetes and subsequent Parkinson disease: A record-linkage cohort study
De Pablo-Fernandez, E., Goldacre, R., Pakpoor, J., Noyce, A. J., & Warner, T. T. (2018) · Neurology · doi:10.1212/wnl.0000000000005771 · Cited by 242
Neurodegeneration by Activation of the Microglial Complement-Phagosome Pathway
Bodea, L.-G., Wang, Y., Linnartz-Gerlach, B., Kopatz, J., Sinkkonen, L., Musgrove, R., Kaoma, T., Muller, A., Vallar, L., Di Monte, D. A., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5002-13.2014 · Cited by 234
Cazareth, J., Guyon, A., Heurteaux, C., Chabry, J., & Petit-Paitel, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-132 · Cited by 206 · cited 4×
“Since microglial cells respond to peripheral inflammatory signals by producing more inflammatory molecules such as TNFα [15, 44], we evaluated the morphology of these in substantia nigra and striatum, the two main areas that show dopamine depletion in Parkinson’s disease [35].”
BackgroundInfluentialTNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
Zhao, C., Ling, Z., Newman, M. B., Bhatia, A., & Carvey, P. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.012 · Cited by 183 · cited 1×
“Single peripheral LPS challenge leads to BBB leakage [48], MPTP administration favors BBB dysfunction, probably secondary to the effect of TNFα [49, 50].”
BackgroundLRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
Choi, I., Kim, B., Byun, J.-W., Baik, S. H., Huh, Y. H., Kim, J.-H., Mook-Jung, I., Song, W. K., Shin, J.-H., Seo, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9255 · Cited by 112
García-Domínguez, I., Veselá, K., García-Revilla, J., Carrillo-Jiménez, A., Roca-Ceballos, M. A., Santiago, M., de Pablos, R. M., & Venero, J. L. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00398 · Cited by 111 · cited 2×
“MPTP and LPS have been proven to act synergistically [50, 98], stimulating microglia activation with inflammatory cytokine production and inducing neurotoxic A1 astrocytes [50].”
BackgroundLai, S.-W., Chen, J.-H., Lin, H.-Y., Liu, Y.-S., Tsai, C.-F., Chang, P.-C., Lu, D.-Y., & Lin, C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0933-z · Cited by 87
Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors
Wang, Y., Ni, J., Zhai, L., Gao, C., Xie, L., Zhao, L., & Yin, X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.015 · Cited by 75
Gu, M., Li, Y., Tang, H., Zhang, C., Li, W., Zhang, Y., Li, Y., Zhao, Y., & Song, C. (2018) · Nutrients · doi:10.3390/nu10101351 · Cited by 73 · cited 1×
“Furthermore, the presence of M1 polarized microglia, the proinflammatory microglial cell, is associated with low BDNF brain levels in an LPS-induced depression-like model [77].”
Background
Cited by
Obesity-induced inflammation: connecting the periphery to the brain
Le Thuc, O., & García-Cáceres, C. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01079-8 · Cited by 125
Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors
Wang, Y., Ni, J., Zhai, L., Gao, C., Xie, L., Zhao, L., & Yin, X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.015 · Cited by 75
Amin, R., Quispe, C., Docea, A. O., Ydyrys, A., Kulbayeva, M., Durna Daştan, S., Calina, D., & Sharifi-Rad, J. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105376 · Cited by 74
Sun, L., Jiang, W.-W., Wang, Y., Yuan, Y.-S., Rong, Z., Wu, J., Fan, Y., Lu, M., & Zhang, K.-Z. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00676-w · Cited by 31
“Systemic inflammation is a crucial factor for glia activation in neurodegeneration [13], however, it is enigmatical where inflammation generates and produces.”
Metadata
- Authors
- Ugalde-Muñiz, P., Fetter-Pruneda, I., Navarro, L., García, E., & Chavarría, A.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2020-01-13
- Volume
- 2020
- Pages
- 1-19
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W3000041679
- Cited by
- 39
- References
- 27
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.